280 related articles for article (PubMed ID: 23522986)
1. Asthma medication delivery: mists and myths.
Rottier BL; Rubin BK
Paediatr Respir Rev; 2013 Jun; 14(2):112-8; quiz 118, 137-8. PubMed ID: 23522986
[TBL] [Abstract][Full Text] [Related]
2. Does Changing Inhaler Device Impact Real-Life Asthma Outcomes? Clinical and Economic Evaluation.
Rhee CK; van Boven JFM; Yau Ming SW; Park HY; Kim DK; Park HS; Ling JZJ; Yoo KH; Price DB
J Allergy Clin Immunol Pract; 2019 Mar; 7(3):934-942. PubMed ID: 30292924
[TBL] [Abstract][Full Text] [Related]
3. Real-life effectiveness of inhaler device switch from dry powder inhalers to pressurized metred-dose inhalers in patients with asthma treated with ICS/LABA.
Park HS; Yoon D; Lee HY; Ban GY; Wan Yau Ming S; Jie JLZ; Carter V; Hardjojo A; Van Boven JFM; Price DB
Respirology; 2019 Oct; 24(10):972-979. PubMed ID: 31038269
[TBL] [Abstract][Full Text] [Related]
4. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K; Noonan M; Silkoff PE; Uryniak T
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[TBL] [Abstract][Full Text] [Related]
5. The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients.
Darbà J; Ramírez G; Sicras A; Francoli P; Torvinen S; Sánchez-de la Rosa R
Int J Chron Obstruct Pulmon Dis; 2015; 10():2335-45. PubMed ID: 26604733
[TBL] [Abstract][Full Text] [Related]
6. [Persistence to treatment by type of inhaler device in patients with asthma and chronic obstructive pulmonary disease].
Sicras A; Ferrer V; Collar JM; Navarro R; Sáez M
Semergen; 2017; 43(5):375-386. PubMed ID: 27425817
[TBL] [Abstract][Full Text] [Related]
7. Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids.
Kaiser H; Parasuraman B; Boggs R; Miller CJ; Leidy NK; O'Dowd L
Ann Allergy Asthma Immunol; 2008 Sep; 101(3):295-303. PubMed ID: 18814453
[TBL] [Abstract][Full Text] [Related]
8. Factors guiding the choice of delivery device for inhaled corticosteroids in the long-term management of stable asthma and COPD: focus on budesonide.
Thorsson L; Geller D
Respir Med; 2005 Jul; 99(7):836-49. PubMed ID: 15939245
[TBL] [Abstract][Full Text] [Related]
9. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
Berger WE; Noonan MJ
J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
[TBL] [Abstract][Full Text] [Related]
10. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
[TBL] [Abstract][Full Text] [Related]
11. Superiority of nebulized corticosteroids over dry powder inhalers in certain patients with cough variant asthma or cough-predominant asthma.
Kamimura M; Izumi S; Hamamoto Y; Morita A; Toyota E; Kobayashi N; Kudo K
Allergol Int; 2012 Sep; 61(3):411-7. PubMed ID: 22627846
[TBL] [Abstract][Full Text] [Related]
12. Use of pressurized metered dose inhalers in patients with chronic obstructive pulmonary disease: review of evidence.
Aggarwal B; Gogtay J
Expert Rev Respir Med; 2014 Jun; 8(3):349-56. PubMed ID: 24802511
[TBL] [Abstract][Full Text] [Related]
13. Inhalatory therapy training: a priority challenge for the physician.
Melani AS
Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
[TBL] [Abstract][Full Text] [Related]
14. InVitro Evaluation of Optimal Inhalation Flow Patterns for Commercial Dry Powder Inhalers and Pressurized Metered Dose Inhalers With Human Inhalation Flow Pattern Simulator.
Hira D; Okuda T; Mizutani A; Tomida N; Okamoto H
J Pharm Sci; 2018 Jun; 107(6):1731-1735. PubMed ID: 29428382
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial.
Zangrilli J; Mansfield LE; Uryniak T; O'Brien CD
Ann Allergy Asthma Immunol; 2011 Sep; 107(3):258-65.e2. PubMed ID: 21875546
[TBL] [Abstract][Full Text] [Related]
16. Evidence-based asthma management.
Kallstrom TJ
Respir Care; 2004 Jul; 49(7):783-92. PubMed ID: 15222910
[TBL] [Abstract][Full Text] [Related]
17. [Approaches to improving therapeutic success].
MMW Fortschr Med; 2014 Jun; 156(12):62-3. PubMed ID: 25369691
[No Abstract] [Full Text] [Related]
18. Dose counting and the use of pressurized metered-dose inhalers: running on empty.
Sander N; Fusco-Walkert SJ; Harder JM; Chipps BE
Ann Allergy Asthma Immunol; 2006 Jul; 97(1):34-8. PubMed ID: 16892778
[TBL] [Abstract][Full Text] [Related]
19. Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids.
Hampel FC; Martin P; Mezzanotte WS
J Asthma; 2008 May; 45(4):265-72. PubMed ID: 18446589
[TBL] [Abstract][Full Text] [Related]
20. Best evidence topic reports. Delivery of bronchodilators in acute asthma in children.
Ferguson C; Gidwani S
Emerg Med J; 2006 Jun; 23(6):471-2. PubMed ID: 16714515
[No Abstract] [Full Text] [Related]
[Next] [New Search]
